Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Lymphoma risk in systemic lupus: effects of disease activity versus treatment.

SLE lymphoma

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 08 March 2014 - 11:26 AM

Lymphoma risk in systemic lupus: effects of disease activity versus treatment.

 

There was a suggestion of higher lymphoma risk with exposure to cyclophosphamide and high cumulative steroids although disease activity itself was not clearly associated with lymphoma risk. PubMed, Ann Rheum Dis. 2014 Jan 1;73(1):138-42. (Also see: Systemic Lupus Erythematosus Symptoms and Lymphoma)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)